GlassScriptPhysician profile
Gabriel A Vidal
NPI 1871788216
$166,888.48
in general payments reported to CMS, 2019-2025
24 companies · $41K in 2025
The $41K reported for 2025 was more than what 97% of Vascular Neurology providers received nationally (typical 2025 total: $360).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $375 · 2021: $8,888 · 2022: $22K · 2023: $32K · 2024: $51K · 2025: $41K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $91K · Travel and Lodging: $28K · Food and Beverage: $5,461.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $90,750.00 |
| Travel and Lodging | $27,577.58 |
| Food and Beverage | $5,461.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $92,251.00 | 2019-2025 | Penumbra System, Smart Coil, Red 72 |
| Astrazeneca Pharmaceuticals LP | $57,201.34 | 2022-2024 | Andexxa |
| Alexion Pharmaceuticals, INC. | $9,313.05 | 2021-2022 | |
| Stryker Corporation | $5,490.44 | 2019-2024 | Trevo, Target |
| Imperative Care, INC | $893.76 | 2020-2025 | Zoom 88-T Large Distal Platform, Tracstar Large Distal Platform |
| Microvention, INC. | $804.77 | 2019-2025 | Stent, Sofia 6f-131cm Str, Web Aneurysm Embolization System |
| Depuy Synthes Sales INC. | $261.15 | 2024 | Trufill, Cerepak Uniform |
| Siemens Medical Solutions USA, INC. | $133.54 | 2021 | |
| Contego Medical, INC | $130.40 | 2024 | |
| Portola Pharmaceuticals, LLC | $67.64 | 2019 | |
| Eisai INC. | $57.31 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $33.86 | 2019-2020 | |
| Medtronic USA, INC. | $33.48 | 2019 | |
| Janssen Pharmaceuticals, INC | $30.94 | 2021 | |
| Terumo Medical Corporation | $26.60 | 2025 | R2p Misago |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $23.21 | 2023 | |
| Medtronic, INC. | $23.08 | 2022 | |
| Medtronic Vascular, INC. | $21.70 | 2019 | |
| Abbvie INC. | $20.52 | 2024 | |
| Gt Medical Technologies, INC | $17.20 | 2019 | |
| Boston Scientific Corporation | $15.62 | 2021 | |
| Amgen INC. | $13.98 | 2019 | |
| Cardinal Health 200 LLC | $12.34 | 2020 | |
| Ucb, INC. | $11.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gabriel Vidal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.